breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged = 55%; 7. AST and ALT= 3.0x10^9 /L, neutrophils >=1.5x10^9 /L;Platelet count >= 100x10^9 /L; Hemoglobin >=90 g/L; 9. Able to understand the research process, participate in the study voluntarily, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. A history of other malignant tumors except breast cancer in the past 5 years; 2. Metastatic breast cancer indicated by imaging or pathology; 3. Uncontrolled pleural effusion, pericardial effusion, ascites; 4. Patients with severe heart disease or discomfort who are expected to be unable to tolerate chemotherapy, including but not limited to: (1)Fatal arrhythmias or higher grade atrioventricular block; (2)Valvular heart disease of clinical significance; (3)The electrocardiogram shows a transmural myocardial infarction; (4)Uncontrollable high blood pressure. 5. The investigator considers that the patient has any other condition that is not suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological complete response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of different types of circulating tumor cells;Expression of FTH1 in different types of circulating tumor cells; | — |
Countries
China
Contacts
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University